Saudade Andre
Overview
Explore the profile of Saudade Andre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peixoto A, Cirnes L, Carvalho A, Andrade M, Brito M, Borralho P, et al.
Front Mol Biosci
. 2024 May;
11:1298522.
PMID: 38721275
[This corrects the article DOI: 10.3389/fmolb.2023.1082915.].
2.
Martins Pereira G, Cristovao M, Dvindenko E, Pinheiro C, Lemos M, Andre S
Diagn Cytopathol
. 2024 Feb;
52(4):225-227.
PMID: 38367019
No abstract available.
3.
Pinto A, Matos J, Pereira T, Silva G, Andre S
Pathol Res Pract
. 2023 May;
246:154513.
PMID: 37167811
Aim: In breast carcinoma (BC), the relationship between the ploidy pattern and molecular subtyping is still unknown. We aim to investigate the prognostic impact of DNA ploidy within molecular subtypes...
4.
Peixoto A, Cirnes L, Carvalho A, Andrade M, Brito M, Borralho P, et al.
Front Mol Biosci
. 2023 Feb;
10:1082915.
PMID: 36825198
Around 40% of ER+/HER2-breast carcinomas (BC) present mutations in the gene. Assessment of mutational status is required to identify patients eligible for treatment with PI3Kα inhibitors, with alpelisib currently the...
5.
Martins-Branco D, Cristovao Ferreira S, Gouveia E, Andre S, Esteves S, Brito M, et al.
Acta Med Port
. 2023 Feb;
36(7-8):487-495.
PMID: 36745867
Introduction: Genomic assays are useful tools for tailoring adjuvant treatment in early breast cancer. We aimed to analyse the role of an institutional protocol of a genomic assay for chemotherapy...
6.
Pinto A, Matos J, Pereira T, Silva G, Andre S
Oncol Lett
. 2022 Aug;
24(4):329.
PMID: 36039057
The influence of age on the outcome of patients with invasive breast carcinoma (IBC) has not yet been fully established. The present study investigated two subgroups of patients either side...
7.
Domenici G, Trindade G, Estrada M, Cartaxo A, Alves P, Andre S, et al.
Methods Mol Biol
. 2022 Jul;
2535:11-31.
PMID: 35867219
Breast cancer is a complex and heterogeneous pathology, characterized by a variety of histological and molecular phenotypes. The majority of the breast cancers express the estrogen receptor alpha (ER), which...
8.
Nunes Silva S, Gomes B, Andre S, Felix A, Rodrigues A, Rueff J
Breast Cancer Res Treat
. 2021 May;
188(1):295-305.
PMID: 33942220
Background: Breast cancer (BC) is the most common cancer in women. In contrast, male BC is about 100 times less common than in women, being considered a rare disease. Male...
9.
Andre S, Pinto A, Silva G, Silva F, Serpa J, Felix A
Breast Cancer (Auckl)
. 2021 Apr;
15:11782234211002496.
PMID: 33888988
Background: Male breast carcinoma (male BC) is an uncommon neoplasia without individualized strategies for diagnosis and therapeutics. Low overall survival (OS) rates have been reported, mostly associated with patients' advanced...
10.
Cartaxo A, Estrada M, Domenici G, Roque R, Silva F, Gualda E, et al.
J Exp Clin Cancer Res
. 2020 Aug;
39(1):161.
PMID: 32807212
Background: Estrogen receptor α (ERα) signaling is a defining and driving event in most breast cancers; ERα is detected in malignant epithelial cells of 75% of all breast cancers (classified...